Health Care Facilities

Inspire Veterinary Partners

Inspire Veterinary Partners released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue USD 12.24 M, actual EPS USD -1.3525

Inspire Veterinary Partners released FY2025 Q3 earnings on November 12, 2025 (EST) with actual revenue of USD 4.316 M and EPS of USD -0.4147

Inspire Veterinary Partners released FY2025 Semi-Annual Earnings on August 13 (EST), Actual Revenue: USD 7.923M, Actual EPS: USD -0.9404

Inspire Veterinary Partners released FY2025 Q2 earnings on August 13 (EST) with actual revenue of USD 4.284 M and EPS of USD -0.5031

Inspire Veterinary Partners released FY2025 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 3.639 M and EPS of USD -0.4347

Inspire Veterinary Partners released FY2024 earnings on March 31 (EST), actual revenue USD 16.59 M, actual EPS USD -2.6094

Inspire Veterinary Partners released FY2024 Q4 earnings on March 31, 2025 (EST), with actual revenue of USD 3.321 M and EPS of USD -0.1846

Inspire Veterinary Partners released FY2024 Q3 earnings on November 13 (EST), with actual revenue of USD 4.049 M and actual EPS of USD -0.8484

Inspire Veterinary Partners released FY2024 9 Months Earnings on November 13 (EST), with actual revenue of USD 13.27 M and EPS of USD -49.178

Inspire Veterinary Partners released FY2024 Q2 earnings on August 14 (EST) with actual revenue of 4.39 M USD and EPS of -17.5941 USD

Inspire Veterinary Partners released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 9.222 M, actual EPS USD -38.9771

Inspire Veterinary Partners released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 4.832M, actual EPS USD -21.9665

Inspire Veterinary Partners released FY2023 Annual Earnings on April 8, 2024 (EST) with actual revenue of 16.68 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2023 Q4 earnings on April 8, 2024 (EST), with actual revenue of 3.784M USD and EPS of 0

Inspire Veterinary Partners released FY2023 9 Months Earnings on November 14 (EST), with actual revenue of 12.89 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2023 Q3 earnings on November 14 (EST), with actual revenue of 4.12 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2022 Semi-Annual Earnings on August 17, 2023 (EST), with actual revenue of 3.731 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2023 Q2 earnings on August 17 (EST), with actual revenue of 4.489 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2022 Q2 earnings on August 17 (EST) with actual revenue of 2.319 M USD and EPS of 0 USD

Inspire Veterinary Partners released FY2023 Semi-Annual Earnings on August 17 (EST), with actual revenue of 8.772 M USD and EPS of 0 USD

Mega Fortune

Processa Pharmaceuticals

Agape ATP

VYNE Therapeutics

cbdMD

Inspirato

Medline Inc.

Globavend

Beneficient

Andersen

Nutex Health

环球保健

Encompass Health

恩赛因

PACS

Concentra Group Holdings Parent

National医疗

Select医药控股

Ardent Health

U.S. Physical Therapy

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap